Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.35 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.34 |
| ▸ | CASP2 | P42575 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24368593 | 0.85 | SLC6A5 (0.38) | SLC6A5KDM4AHIF1ATET2DOHH | |
| SCHEMBL19463227 | 0.81 | USP14 (0.32) | CASP2 | |
| SCHEMBL22569945 | 0.81 | USP14 (0.32) | CASP2 | |
| SCHEMBL12300506 | 0.78 | PGK1 (0.40) | — | |
| SCHEMBL9799140 | 0.78 | CASP2 (0.31) | CASP2TSHRNAAA | |
| SCHEMBL16248720 | 0.77 | SLC6A5 (0.44) | SLC6A5KDM4AHIF1ATET2DOHH | |
| SCHEMBL15044593 | 0.77 | CNR2 (0.31) | — | |
| SCHEMBL15160668 | 0.76 | MCL1 (0.41) | LMNA | |
| SCHEMBL10033884 | 0.76 | EPHX2 (0.31) | HDAC6 | |
| SCHEMBL9799143 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026627-A1 | Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery | VACCITECH NORTH AMERICA, INC. (US) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026627-A1 | Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery | TNFSF10, SELPLG, FCGRT | SLC6A5 4867/4885KDM4A 4351/4885HIF1A 3656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.